Aerovate Therapeutics, Inc. (AVTE)
NASDAQ: AVTE · IEX Real-Time Price · USD
20.57
-1.34 (-6.12%)
May 17, 2024, 4:00 PM EDT - Market closed
Aerovate Therapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for AVTE stock have an average target of 47, with a low estimate of 35 and a high estimate of 65. The average target predicts an increase of 128.49% from the current stock price of 20.57.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for AVTE stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 1 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 1 | 2 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Buy Reiterates $41 | Buy | Reiterates | $41 | +99.32% | May 14, 2024 |
| Wells Fargo | Wells Fargo | Buy Maintains $35 | Buy | Maintains | $35 | +70.15% | Apr 1, 2024 |
| Jefferies | Jefferies | Strong Buy Initiates $21 → $65 | Strong Buy | Initiates | $21 → $65 | +215.99% | Mar 25, 2024 |
| Guggenheim | Guggenheim | Strong Buy Initiates $36 | Strong Buy | Initiates | $36 | +75.01% | Mar 1, 2023 |
| BTIG | BTIG | Hold → Strong Buy Upgrades $27 | Hold → Strong Buy | Upgrades | $27 | +31.26% | Dec 6, 2022 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-3.08
from -2.87
EPS Next Year
-3.02
from -3.08
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | 42.8M | 154.4M | 380.1M |
| Avg | n/a | n/a | 12.9M | 70.2M | 193.1M |
| Low | n/a | n/a | n/a | n/a | 45.0M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | 1,094.1% | 441.5% |
| Avg | - | - | - | 443.0% | 175.1% |
| Low | - | - | - | - | -35.9% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -2.77 | -2.79 | -1.79 | -4.41 | -3.61 |
| Avg | -3.08 | -3.02 | -3.15 | -4.28 | -3.51 |
| Low | -3.35 | -3.20 | -3.54 | -4.12 | -3.37 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.